Buprenorphine and Methadone for Opioid Dependent Chronic Pain Patients
CompletedPhase 4NCT00879996
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The purpose of this study is to determine if buprenorphine or methadone is better for the treatment of chronic pain among patients who have become addicted to prescription narcotics.
Study details
- Official title
- A Randomized Controlled Trial Comparing Buprenorphine and Methadone for Opioid Dependent Chronic Pain Patients
- Conditions
- Opiate Addiction
- Interventions
- Drug: Methadone
- Drug: Buprenorphine/naloxone
- Sponsor
- State University of New York at Buffalo
- Collaborators
- National Institute on Alcohol Abuse and Alcoholism (NIAAA); National Institute on Drug Abuse (NIDA)
- Start date
- 2009-04
- Primary completion
- 2011-10
- Sex
- All
- Age range
- from 18 Years
- Healthy volunteers
- true
- Results posted
- Yes, on ClinicalTrials.gov
- Countries
- United States
- Total sites listed
- 2
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * chronic back pain * opioid addiction * not successful with abstinence * at least 18 years old * able to understand spoken English * live in Western New York State (Erie or Niagara county) * have health insurance or ability to pay for health care * no methadone or buprenorphine treatment within past year * not member of a vulnerable population (e.g., pregnancy, prisoner) Exclusion Criteria: * homelessness * unable to give consent (e.g., dementia, psychosis) * serious heart or lung disease * taking a medication that could interact with methadone or buprenorphine * pregnancy
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT00879996